Evidence map›Paper›PMID 39000753›Full record

ArticlePolymers2024

Cellulose Acetate Microparticles Synthesized from

Larissa Pereira Alves, Kevin da Silva Oliveira, Ana Cláudia Gonçalves Dos Santos, Demis Ferreira de Melo, Lívia Maria Coelho de Carvalho Moreira, João Augusto Oshiro Junior, Dayanne Tomaz Casimiro da Silva, Airlla Laana de Medeiros Cavalcanti, Bolívar Ponciano Goulart de Lima Damasceno

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Larissa Pereira AlvesGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.ORCID 0000-0002-2195-8440
Kevin da Silva OliveiraGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.
Ana Cláudia Gonçalves Dos SantosLaboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Paraíba State University, Campina Grande 58429-600, PB, Brazil.
Demis Ferreira de MeloGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.ORCID 0000-0001-8486-5578
Lívia Maria Coelho de Carvalho MoreiraGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.
João Augusto Oshiro JuniorGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.ORCID 0000-0001-7247-1598
Dayanne Tomaz Casimiro da SilvaGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.ORCID 0000-0003-3872-3813
Airlla Laana de Medeiros CavalcantiLaboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Paraíba State University, Campina Grande 58429-600, PB, Brazil.
Bolívar Ponciano Goulart de Lima DamascenoGraduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil.ORCID 0000-0002-0747-0297

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001National Council for Scientific and Technological Development 453940/2014-5Universidade Estadual da Paraíba PROPESQ-854 UEPB 4.03.00.00-5-400/2017-1
6 · The paper itself

Abstract

Simvastatin (SIM) is widely prescribed to treat hyperlipidemia, despite its limitations, such as a short half-life and low oral bioavailability. To overcome these drawbacks, the development of a controlled-release formulation is desirable. This study aims to develop a microparticulate system based on cellulose acetate (ACT) obtained from

Indexed as

bioavailabilitycellulosecontrolled releasemicroencapsulationnew drug release systems

Identifiers

PMID39000753
PMCPMC11243862

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.